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Regulation of Vav Localization in Membrane Rafts
by Adaptor Molecules Grb2 and BLNK
development and activation has been recently under-
scored by gene targeting experiments in both mice and
cell lines. The B cell developmental and functional
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Katsuhiko Hayashi,4 Elena Vigorito,5
Daisuke Kitamura,4 Martin Turner,5 anomalies are relatively mild in mice lacking either Vav1
or Vav2, while double-deficient mice exhibit more severeKoh Shingu,2 Masaki Hikida,1
and Tomohiro Kurosaki1,3,* defects including a large decrease in peripheral mature
B cell numbers, an almost complete loss of T cell-inde-1Department of Molecular Genetics
Institute for Liver Research pendent type II (TI-II) antibody responses, and the virtual
loss of BCR-mediated proliferation and calcium mobili-2 Department of Anesthesiology
Kansai Medical University zation (Doody et al., 2001; Tedford et al., 2001). The
BCR-induced calcium mobilization is also decreased10-15 Fumizono-cho, Moriguchi 570-8506
3 Laboratory for Lymphocyte Differentiation in Vav3-deficient DT40 B cells and this defect can be
compensated for by overexpression of Vav2 (Inabe etRIKEN Research Center for Allergy and Immunology
10-15 Fumizono-cho, Moriguchi 570-8506 al., 2002). Hence, in addition to the importance of the
Vav family members, the above data have demonstrated4 Research Institute for Biological Science
Science University of Tokyo the possibility that Vav1, Vav2, and Vav3 possess over-
lapping functions in the BCR signaling context. ThisYamazaki 2669, Noda 278-0022
Japan idea could be further supported by the evidence that
overexpression of Vav1 or Vav2 gives rise to a similar5 Laboratory of Lymphocyte Signaling and Development
Molecular Immunology Programme phenotype such as augmentation of BCR-mediated cal-
cium flux and the subsequent NF-AT activation in Bal-The Babraham Institute
Babraham, Cambridge CB2 4AT 17 B cells (Doody et al., 2000).
Despite the wealth of evidence that establishes theUnited Kingdom
biological roles of the Vav family proteins, how they are
activated during BCR engagement still remains unclear.
CD19, a coreceptor on B cells, is thought to participateSummary
in activation of Vav proteins. Both Vav1 and Vav2 have
been shown to interact, by means of their SH2 domain,Despite the importance of the Vav family proteins for
with the tyrosine phosphorylated Y391EEP in the cyto-B cell receptor (BCR) signaling, their activation mecha-
plasmic tail of CD19 (Doody et al., 2000; Fujimoto et al.,nisms remain poorly understood. We demonstrate
2000; O’Rourke et al., 1998), which could provide anhere that adaptor molecules Grb2 and BLNK, in addi-
explanation for the decreased tyrosine phosphorylationtion to Vav, are required for efficient Rac1 activation
of Vav1 in CD19-deficient B cells (Sato et al., 1997).in response to BCR stimulation. Loss of either Grb2
However, given that BCR signaling defects such as cal-or BLNK results in decreased translocation of Vav3
cium mobilization in Vav1–/–Vav2–/– B cells are more se-to membrane rafts. By expression of Vav3 as a raft-
vere than those in CD19–/– B cells (Doody et al., 2001;targeted construct, the defective Rac1 activation in
Engel et al., 1995; Fujimoto et al., 1999; O’Rourke et al.,Grb2- or BLNK-deficient B cells is restored. Hence,
1998; Rickert et al., 1995; Tedford et al., 2001), thisour findings suggest that Grb2 and BLNK cooperate
CD19-mediated mechanism appears not to fully accountto localize Vav into membrane rafts, thereby contribut-
for the activation mode of the Vav proteins.ing to optimal activation of Vav in B cells.
In this regard, a family of adaptor molecules has been
suggested recently that might play key roles in Vav acti-Introduction
vation. Of these, BLNK (also known as SLP-65, BASH,
and BCA), like SLP-76 in T cells (Koretzky and Myung,The Vav family proteins (Vav1, Vav2, and Vav3), which
2001), undergoes tyrosine phosphorylation upon BCRare rapidly phosphorylated and activated upon B cell
engagement (Campbell, 1999; Fu et al., 1998; Wienandsreceptor (BCR) engagement, provide a link from the BCR
et al., 1998), thereby providing a binding site for the SH2to the Rho family of GTPases like Rac1. These Rho
domain of the Vav proteins. In addition, Grb2, by virtueproteins are molecular switches that shuttle between
of its carboxy-terminal SH3 domain, has been reportedan “inactive” GDP-bound state and an “active” GTP-
to bind to the proline-rich region located in the amino-bound state; GTP-bound Rho proteins bind to and con-
terminal SH3 domain of Vav1 (Nishida et al., 2001;trol the activity of multiple downstream effectors (Bus-
Ramos-Morales et al., 1995; Ye and Baltimore, 1994).telo, 2000; DeFranco, 2001; Gulli and Peter, 2001; Turner
Accordingly, we have addressed a key question ofand Billadeau, 2002).
whether or how BLNK and/or Grb2 regulate BCR-medi-The importance of the Vav family proteins for B cell
ated Vav activation. Our results show that both Grb2 and
BLNK participate in translocation of Vav3 to membrane*Correspondence: kurosaki@mxr.mesh.ne.jp
rafts, thereby contributing to optimal activation of Vav36Present address: Yamanouchi Pharmaceutical Comp., Tsukuba
305-8585, Japan. during BCR engagement.
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Results
Requirement for Grb2 and BLNK in BCR-Mediated
Vav Activation
Previous studies showing that Vav proteins bind to Grb2
and BLNK (Fu et al., 1998; Nishida et al., 2001; Ramos-
Morales et al., 1995; Wienands et al., 1998; Ye and Balti-
more, 1994) prompted us to examine whether these
adaptor molecules indeed play a critical role in Vav acti-
vation during BCR engagement. Two sets of observa-
tions allowed us to take the avian B cell line DT40 for
this purpose. First, Vav3-deficient DT40 B cells exhibited
a decrease in BCR-mediated Rac1 activation (Inabe et
al., 2002). Second, this defective Rac1 activation in
Vav3-deficient DT40 cells was restored by overexpres-
sion of avian Vav2 (Inabe et al., 2002) or human Vav1
(data not shown), suggesting that these three Vav iso-
forms (Vav1, Vav2, and Vav3) possess an overlapping
function in BCR-mediated Rac1 activation. Hence, as a
readout of BCR-mediated Vav activation in DT40 B cells,
we used Rac1 activation. As shown in Figure 1A, when
compared to wild-type DT40 B cells, BCR-mediated
Rac1 activation was decreased by 50% or 40% in
Grb2- or BLNK-deficient DT40 B cells (Hashimoto et al.,
1998; Ishiai et al., 1999), respectively. This decrease
cannot be ascribed to decreased expression of Vav3,
Vav2, or BCR in these mutant cell lines (Figures 1B and
1C). Moreover, introduction of Grb2 or BLNK in each
deficient cell line restored Rac1 activation (data not
shown). Collectively, we conclude that both Grb2 and
BLNK participate in BCR-mediated Vav activation in
DT40 B cells.
To assess whether the above conclusion also applies
to primary B cells, we used B cells from BLNK/ or
Vav1/Vav2/ mice (Doody et al., 2001; Hayashi et al.,
2000). Since B cells from BLNK/ or Vav1/Vav2/
mice exhibit an immature phenotype rather than a ma- Figure 1. Requirement for Grb2 and BLNK in BCR-Mediated Rac1
Activationture one (Doody et al., 2001; Hayashi et al., 2000; Jumaa
(A) BCR-mediated Rac1 activation in wild-type, Grb2-, or BLNK-et al., 1999; Pappu et al., 1999; Tedford et al., 2001; Xu
deficient DT40 B cells. Cells (5  106 cells/lane) were stimulatedet al., 2000), immature B cells from littermates, sorted
with M4 (4 g/ml) and cell lysates were mixed with beads containingby mAb 493, were used as controls. In these prepara-
the CRIB of PAK. Elutes of the beads (top panel) or cell lysatestions, the expression level of BCR was indistinguishable
(bottom panel) were subjected to Western blot analysis with anti-
between Vav1/Vav2/, BLNK/, and control B cells Rac mAb. Stimulation folds of Rac1 activity are shown below. In
(Figure 2A). As predicted from the data using Vav1/ Figures 2A, 5C, 6B, and 7B, stimulation folds of Rac1 activity are
T cells (Fischer et al., 1998; Holsinger et al., 1998; Kraw- similarly shown. AP, affinity precipitation.
(B) Protein expression analysis of chicken Vav3 and Vav2. Total cellczyk et al., 2000), the BCR-mediated Rac1 activation
lysates (2.5 106 cells/lane) were prepared and analyzed by Westernwas decreased by 40% in the absence of both Vav1
blotting using anti-chicken Vav3 and anti-chicken Vav2 Abs. -actinand Vav2 (Figure 2A). The residual Rac1 activation is
was used as a loading control.likely to be derived by Vav3, since mouse B cells express
(C) Cell surface expression of BCR on wild-type, Grb2-, BLNK-, or
Vav3, in addition to Vav1 and Vav2 (Inabe et al., 2002; double-deficient DT40 cells. Analyses of transformants expressing
Tedford et al., 2001). Similar to Vav1/Vav2/ B cells, a LAT/Vav3 chimera, its GEF mutant (LAT/Vav3(mGEF)), its LAT
the Rac1 activation was also inhibited in BLNK/ B mutant (LAT(mCS)/Vav3), or native Vav3 in Grb2- or BLNK-deficient
cells are also shown here (see also Figure 5).cells (Figure 2A).
(D) Vav3 phosphorylation in wild-type, Grb2-, or BLNK-deficientBecause Grb2/mice result in early embryonic lethal-
DT40 cells. Cells (5  106 cells/lane) were incubated with M4 (4 g/ity (Cheng et al., 1998), we took an approach of introduc-
ml). Then, the immunoprecipitates with anti-Vav3 Ab were analyzeding a dominant-negative form of Grb2 into primary B
by Western blotting with 4G10 mAb (top panel) and anti-Vav3 Ab
cells by using a retroviral system. Since the above bio- (bottom panel). Stimulation folds of phosphorylation are shown be-
chemical assay needs a large amount of infected pri- low. In Figures 5D and 7D, stimulation folds are similarly shown.
mary B cells, we circumvented this difficulty by em-
ploying a cap formation assay. In fact, it was already
is critical for its association with Vav1 (Nishida et al.,reported that cap formation following antigen receptor
2001; Ramos-Morales et al., 1995; Ye and Baltimore,stimulation requires Vav proteins (Fischer et al., 1998;
1994), Grb2 devoid of this SH3 domain (Rodrigues etHolsinger et al., 1998; Krawczyk et al., 2002). Given the
evidence that the carboxy-terminal SH3 domain of Grb2 al., 1997; Wang and Moran, 1996) was subcloned into the
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Figure 2. Requirement for Vav, BLNK, and
Grb2 in BCR-Mediated Rac1 Activation and
Cap Formation in Primary B Cells
(A) BCR-mediated Rac1 activation in wild-
type, BLNK/, or Vav1/ Vav2/ mice
splenic B cells. Splenic B cells (7.5 106 cells/
lane) were incubated with anti-mouse IgM (12
g/ml) and Rac1 activation was measured as
described in Figure 1. 493 B cells were puri-
fied and used in the case of wild-type mice
(top panel). Expression of B220, IgM, and IgD
in purified B cells from each mice was ana-
lyzed (bottom panel).
(B) Effects of retroviral transduction of domi-
nant-negative Grb2 on BCR-mediated cap
formation. Infected cells were treated with 2
g/ml biotinylated anti-IgM on ice for 20 min.
Stimulated cells were then washed with ice-
cold PBS and directly fixed with 0.4% PFA
(minus symbol) or incubated in the presence
of 1 g/ml anti-rat IgG at 37C for 10 min
followed by fixation (plus symbol). BCR clus-
tering was visualized by staining with TRITC-
conjugated avidin. BCR clustering in GFP
uninfected and GFP infected B cells is
shown. Right panel shows mean percentages
(% SD) of GFP and GFP B cells that have
formed BCR caps. At least 200 cells were
counted for each sample using confocal laser
microscope.
MSCV vector containing a bicistronic mRNA encoding viously (Arudchandran et al., 2000; Bi et al., 2001; Guo
GFP. Indeed, overexpression of this mutated Grb2 in et al., 2000; Xavier et al., 1998), Vav3 was barely detect-
wild-type DT40 B cells, like Grb2-deficient DT40 cells, able in rafts in unstimulated wild-type DT40 cells. After
inhibited BCR-mediated Rac1 activation (data not 1 min of BCR stimulation, this Vav3 residency in the
shown). As shown in Figure 2B, GFP primary B cells rafts was significantly increased. By contrast, this BCR-
manifested a significant decrease in cap formation, mediated recruitment at 1 min was significantly attenu-
compared with GFP– cells. Together, these observations ated in Grb2-deficient cells, while this attenuation was
suggest that in primary B cells, both Grb2 and BLNK small in BLNK-deficient cells (Figure 3A). Presumably
are involved in BCR-mediated Vav activation. reflecting the status of this initial recruitment of Vav3,
its tyrosine phosphorylation upon BCR engagement was
reduced by 40% in Grb2-deficient DT40 B cells,Translocation of Vav3 to Membrane Rafts
whereas this phosphorylation in BLNK-deficient cells wasBased on previous findings that Vav1 is translocated to
almost the same level as in wild-type cells (Figure 1D).membrane rafts upon TCR, BCR, and FcRI engagement
High levels of Vav3 still remained in the rafts of wild-(Arudchandran et al., 2000; Bi et al., 2001; Cherukuri
type DT40 cells after 10 min stimulation. However,et al., 2001; Guo et al., 2000; Xavier et al., 1998), we
BLNK-deficient cells exhibited barely detectable trans-hypothesized that Grb2 and BLNK might be involved in
location of Vav3 in the rafts after 10 min (Figure 3A,BCR-induced redistribution of Vav proteins into the
bottom panel). To further substantiate that BLNK partici-rafts. To test this idea, we examined the BCR-mediated
pates in the prolonged residency of Vav3 in lipid rafts,translocation of Vav3 in wild-type, BLNK-, or Grb2-defi-
the time kinetics of Vav3 redistribution from the raftscient DT40 cells by fractionation of DT40 cell lysates
were monitored after washing out the stimulating anti-over a sucrose step-gradient. Consistent with the previ-
body. As shown in Figure 3B, in wild-type DT40 B cellsous reports (Aman and Ravichandran, 2000; Cheng et
Vav3 was still localized to some extent in lipid rafts byal., 1999), Lyn was enriched in Triton-insoluble rafts
(mainly fraction number 4). Like Vav1 as reported pre- 60 min, while its residency in the rafts was starting on
Immunity
780
Figure 3. Grb2 and BLNK Are Involved in Vav3 Localization in Lipid Rafts upon BCR Engagement
(A) Translocation of Vav3 to lipid rafts. Wild-type, BLNK-, or Grb2-deficient DT40 B cells, unstimulated (minus symbol) or stimulated with M4
for 1 min (plus symbol), were lysed and fractionated in sucrose gradient centrifugation (see Experimental Procedures). Vav3 (top panel) and
Lyn (middle panel) were determined by Western blotting with their respective Abs. In the bottom panel, translocation kinetics of Vav3 to lipid
rafts were obtained from B cells stimulated for 1, 3, or 10 min. Only raft fractions (fr 4) are shown. Lyn was used as a positive control for raft
fraction. The stimulation folds are shown below.
(B) Translocation kinetics of Vav3 from lipid rafts in wild-type or BLNK-deficient DT40 B cells. DT40 B cells were incubated with M4 (4 g/
ml) at 4C for 5 min, washed, and warmed to 37C for 0, 10, 30, or 60 min. Thus, “0” time in this figure is a point after 5 min BCR stimulation.
Then the cells were lysed, fractionated in sucrose gradient centrifugation, and blotted with anti-Vav3 Ab. Only raft fractions (fr 4) are shown.
Lyn was used as a positive control for raft fraction. The stimulation folds are shown below. In Figures 4 and 7C, stimulation folds are similarly
shown.
(C) Phosphorylation of Vav3 in lipid rafts. Samples from fraction 4 were immunoprecipitated with anti-Vav3 Ab and analyzed by Western
blotting with 4G10 mAb (top panel), and the amounts of Vav3 in lipid rafts were determined by blotting with anti-Vav3 Ab (middle panel). Lyn
was used as a positive control for raft fraction (bottom panel).
attenuation at 10 min in BLNK-deficient B cells. Taken periments did not address whether this translocation
defect causes insufficient Rac1 activation in Grb2- ortogether, these observations suggest that Grb2 pro-
motes translocation of Vav3 to rafts, while BLNK rather BLNK-deficient cells. To answer this question, a chimera
including regions of LAT and Vav3 (LAT/Vav3) and itsfunctions to sustain its residency in the rafts during
BCR engagement. The phosphotyrosine levels of raft- mutant (LAT(mCS)/Vav3) was expressed in Grb2- or
BLNK-deficient DT40 B cells. As illustrated in Figureassociated Vav3 appeared to reflect its content in the
rafts (Figure 3C), implying the importance of raft recruit- 5A, the amino terminus of the chimera consists of the
extracellular and transmembrane domains and a limitedment for initiating tyrosine phosphorylation of Vav3.
Grb2 and BLNK did not influence each other’s translo- portion of the cytoplasmic tail of LAT, including the two
cysteine residues (C26 and C29) previously shown tocation after BCR engagement (Figure 4). Furthermore,
translocation of BLNK or Grb2 normally occurred in be necessary and sufficient for raft localization of LAT
(Boerth et al., 2000; Lin et al., 1999; Zhang et al., 1998).Vav3-deficient DT40 cells (data not shown).
Consistent with a previous report using RBL cells Indeed, the LAT mutant in which C26 and C29 are
changed to serine residues is incapable of partitioning(Arudchandran et al., 2000), we also found that Rac1,
the target of Vav3, was constitutively present in rafts into lipid rafts (Boerth et al., 2000). We also transfected
native Vav3 into these deficient cells, referred to asand its presence in the rafts was increased by BCR
stimulation in wild-type DT40 B cells. This Rac1 translo- Vav3(Grb2) and Vav3(BLNK) in Figures 5B and 5C. As
expected, the LAT/Vav3 chimera, but not LAT(mCS)/cation status was not changed by loss of Grb2 or BLNK
(Figure 4). Vav3, was constitutively localized in the rafts (Figure 5B,
third panel). As shown in Figure 5C, Rac1 activation
status at resting level was slightly increased by expres-Targeting Vav3 to Membrane Rafts Replaces the Need
for Grb2 and BLNK in DT40 B Cells sion of LAT/Vav3 in either Grb2- or BLNK-deficient cells.
When ligated by BCR, these deficient B cells harboringWhile the requirement for Grb2 and BLNK in normal
translocation of Vav3 was shown in Figure 3, these ex- LAT/Vav3 exhibited a significant increase in Rac1 activa-
Regulation of Vav by Grb2 and BLNK
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Figure 4. Translocation of BLNK, Grb2, and Rac1 to Lipid Rafts
As in Figure 3A, all fractions after 1 min stimulation and translocation kinetics into the raft fractions (fr 4) after 1 and 10 min stimulation are
shown by each top and bottom panels, respectively. Blotting for Lyn was shown only in the bottom panel, since all the fractions in each panel
are derived from the same sample.
tion to such an extent as wild-type DT40 cells, while the dextrin (MCD), which results in the dispersion of the
cholesterol-rich lipid rafts (Cheng et al., 1999; Harder etmutated chimera (LAT(mCS)/Vav3) failed to do so. A
LAT/Vav3 chimera with an inactive guanine-nucleotide al., 1997). Membrane rafts could be visualized by the
glycosphingolipid GM1 binding cholera toxin B subunitexchange factor (GEF) domain was unable to restore
Rac1 activation in these deficient cells. Moreover, the conjugated to FITC. As shown in Figure 6A, nontreated
control DT40 B cells displayed increased raft polariza-rescue by the LAT/Vav3 chimera was not simply a reflec-
tion of the higher expression level of the Vav3 portion, tion after BCR stimulation, whereas treatment with 10
mM MCD failed to induce this clustering. This MCDsince overexpression of native Vav3 did not restore Rac1
activation (Figure 5C). Together, these data suggest that treatment reduced Rac1 activation and 12.5 mM MCD
blocked it more severely, supporting the importance ofraft targeting of Vav3 can overcome the need for Grb2
or BLNK in Rac1 activation during BCR engagement. the integrity of membrane rafts in BCR-mediated Rac1
activation (Figure 6B). However, we cannot completelyIn unstimulated Grb2-deficient DT40 B cells express-
ing LAT/Vav3, there was no detectable tyrosine phos- exclude the possibility that MCD treatment might per-
turb early signaling events such as PTK activation, whichphorylation of LAT/Vav3 like native Vav3. Upon BCR
ligation, its phosphorylation was augmented, at least in turn blocks Rac1 activation.
1.5-fold, compared with native Vav3. As expected from
the apparently normal tyrosine phosphorylation of Vav3 Impaired Rac1 Activation in Grb2/BLNK
in BLNK-deficient B cells (Figure 1D), tyrosine phosphor- Double-Deficient DT40 B Cells
ylation status was not significantly changed between The above results suggest that both Grb2 and BLNK
LAT/Vav3 and native Vav3 in a BLNK-deficient back- contribute to translocation of Vav3 into lipid rafts in
ground (Figure 5D). differential manners; Grb2 induces translocation of
Vav3, while BLNK sustains its residency in the rafts. This
conclusion predicts that BCR-mediated Rac1 activationRole of Rafts in Rac1 Activation
upon BCR Engagement will be further impaired in Grb2/BLNK double-deficient
B cells. A direct comparison of Rac1 activation in single-To verify that intact lipid rafts are important for BCR-
mediated Rac1 activation, DT40 B cells were treated or double-deficient DT40 B cells is shown in Figure 7B.
In contrast to a reduction by 40 to 50% in single-with the cholesterol-sequestering drug methyl--cyclo-
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Figure 5. Expression of Raft-Targeted Vav3
Suppresses Grb2 or BLNK Inhibition
(A) Schematic diagram of the LAT/Vav3 chi-
mera (top), its GEF mutant (middle), and its
LAT(CS) mutant (bottom). The amino termi-
nus contains LAT amino acids 1-35, including
the LAT extracellular domain, transmem-
brane domain, and amino acids surrounding
cysteines 26 and 29. The chimeras include
the entire chicken Vav3, its GEF mutant, or
LAT mutant with point mutation altering cys-
teines 26 and 29 to serines.
(B) Expression of Vav3 and chimeras. Grb2-
or BLNK-deficient DT40 B cells expressing
exogenous native Vav3 are shown by
Vav3(Grb2) or Vav3(BLNK), respectively.
Hence, the expression level of Vav3 in these
cells is a summation of endogenous and ex-
ogenous Vav3. Whole-cell lysates prepared
from 2  106 cells were analyzed by Western
blotting using anti-Vav3 Ab. Relative expres-
sion levels of Vav3 in these cells are between
2.7- and 3.0-fold compared to the level in
their corresponding parental Grb2- or BLNK-
deficient DT40 cells (top panel). -actin was
used as a loading control (second panel). The
third panel shows expression of LAT/Vav3,
its GEF mutant, its LAT(CS) mutant, or native
Vav3 in lipid rafts before BCR stimulation.
Among 12 fractions, fraction 4 is demon-
strated (see Figure 3). Fold increase values
of Vav3 amounts in lipid rafts compared to
the level of corresponding parental cells are
as follows: Grb2 (1), LAT/Vav3(Grb2) (4.1),
LAT/Vav3(mGEF)(Grb2) (4.8), Vav3(Grb2)
(1.9), LAT(mCS)/Vav3(Grb2) (1.5), BLNK (1),
LAT/Vav3(BLNK) (3.9), LAT/Vav3(mGEF)
( B L N K ) (3.8), V a v 3 ( B L N K ) (1.7), and
LAT(mCS)/Vav3(BLNK) (1.4). Lyn was used
as a control for raft fraction (fourth panel).
(C) BCR-mediated Rac1 activation in various
mutant DT40 cells was carried out as in Figure
1. Each experiment was repeated at least
three times. Mean values for each samples
(average  SD) at 1 min are as follows: Grb2
(1.9  0.2), LAT/Vav3(Grb2) (3.4  0.2),
LAT(mCS)/Vav3(Grb2) (2.0 0.2), LAT/Vav3-
(mGEF)(Grb2) (1.9 0.2), Vav3(Grb2) (2.3
0.1), BLNK (2.0  0.2), LAT/Vav3(BLNK)
(3.5  0.3), LAT(mCS)/Vav3(BLNK) (2.1 
0.1), LAT/Vav3(mGEF)(BLNK) (2.4  0.2), and Vav3(BLNK) (2.1  0.2).
(D) Phosphorylation of LAT/Vav3, its LAT(CS) mutant, or native Vav3. Western blotting with 4G10 mAb (top panel) and anti-Vav3 Ab (bottom
panel) are shown.
deficient cells, deletion of both adaptor molecules re- mained unclear. In this study, we provide evidence that
both Grb2 and BLNK are required for stable localizationsulted in a more severe block of Rac1 activation. Raft
translocation of Vav3 and its tyrosine phosphorylation of Vav3 in lipid rafts upon BCR engagement. The neces-
sity of its raft translocation for subsequent Rac1 activa-were aggravated in double-deficient DT40 B cells (Fig-
ures 7C and 7D). Therefore, these findings suggest that tion reinforces the concept that these membrane micro-
domains function as platforms to initiate BCR signalGrb2 and BLNK act in concert to mediate Vav activation.
In addition, the residual Rac1 activation, albeit small, in transduction (Pierce, 2002).
Based on models of transmembrane receptor tyrosinethe double-deficient B cells implies participation of other
molecule(s) in coupling BCR to Vav activation. kinases (Pawson and Scott, 1997; Schlessinger, 2000), it
had been expected that recruitment of the Grb2 adaptor
protein, which is associated with Sos GEF, to the plasmaDiscussion
membrane is a likely mechanism for Ras and ERK activa-
tion in the case of antigen receptor signaling. However,Despite the importance of the Vav family proteins for B
cell development and BCR signaling, the exact nature in addition to the Grb2-Sos pathway, recent studies have
also shown that PLC-	-RasGRP plays a crtitical role inof the connection between BCR and Vav activation re-
Regulation of Vav by Grb2 and BLNK
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Figure 6. Rac1 Activation Requires Intact Lipid Rafts
(A) Dispersion of lipid rafts by MCD treatments, detected by staining
with FITC-conjugated cholera toxin B subunit. DT40 B cells were
treated with (MCD) or without (MCD) 10 mM MCD. Cells were
then treated in the presence (plus symbol) or absence (minus sym-
bol) of 5g/ml M4 and BCR-mediated raft polarization was analyzed.
(B) Rac1 activation in MCD treated DT40 B cells. DT40 B cells were
treated with indicated concentrations of MCD. Cells were then stim-
ulated with M4 and Rac1 activation was measured as in Figure 1.
Figure 7. More Impaired Rac1 Activation in Grb2/BLNK Double-
Deficient DT40 B Cells
Ras activation in the TCR signaling context (Dower et (A) Protein expression analysis of BLNK, Grb2, Vav2, and Vav3. Total
cell lysates (2.5  106 cells/lane) were prepared and analyzed byal., 2000; Ebinu et al., 1998, 2000). The latter pathway
Western blotting using anti-BLNK Ab, anti-Grb2 Ab, anti-Vav2 Ab,appears to dominantly operate in DT40 B cells, as a PLC-
and anti-Vav3 Ab. -actin was used as a loading control.	2-deficient DT40 mutant manifested a large decrease in
(B) BCR-mediated Rac1 activation was carried out as in Figure 1.BCR-mediated ERK activation, in contrast to relatively
(C) Translocation of Vav3 to lipid rafts. Only raft fractions (fr 4) are
less affected ERK activation in Grb2-deficient cells (Ha- shown. Lyn was used as a positive control for raft fraction.
shimoto et al., 1998). This could be further supported (D) Detection of Vav3 phosphorylation in Grb2/BLNK double-defi-
cient DT40 B cell was carried out as in Figure 1.by our observation that ablating Sos2, a dominantly ex-
pressed Sos isoform in DT40 cells, barely affected the
ERK activation (A. Hashimoto and T.K., unpublished
data). Hence, considering the above observations, the Our data suggest that Grb2 facilitates the recruitment
of Vav3 and its subsequent activation in lipid rafts. Givendata presented here allow us to propose that Grb2 plays
a more dominant role in coupling BCR to Rac rather the association of the carboxy-terminal SH3 domain of
Grb2 with the proline-rich region located in the amino-than Ras activation. Additional studies are underway to
further define the relative importance of Grb2 for Rac terminal SH3 domain of Vav1 (Nishida et al., 2001;
Ramos-Morales et al., 1995; Ye and Baltimore, 1994),versus Ras pathway in B cells.
Given the importance of Rac in JNK activation, normal Grb2 might utilize this physical interaction for transloca-
tion of Vav3 to the rafts. However, even in the absenceBCR-mediated JNK activation in Grb2-deficient DT40
B cells was unexpected (data not shown). Grb2 was of Grb2, Vav3 still moved to rafts, at least to some extent
(Figure 3A), suggesting that Grb2 family proteins or otherreported to bind to SHIP (Harmer and DeFranco, 1999),
a PIP3 hydrolyzing enzyme, in addition to Vav proteins. molecules still support Vav3 translocation upon BCR
engagement. Involvement of the Grb2 family would beAs the JNK response requires both Rac1 and PIP3 (Inabe
et al., 2002), it would be possible that deletion of Grb2 unlikely, because Grb2/Grap double-deficient cells (Liou
et al., 2000) did not show more severe defects than Grb2causes defects in both positive (Rac) and negative
(SHIP) regulators, together resulting in the normal JNK single-deficient cells (data not shown). Instead, it would
be more likely that CD19 contributes to Vav3 recruitmentresponse. Indeed, the enhanced Akt activation in Grb2-
deficient DT40 cells (data not shown) appears to make to membrane rafts together with Grb2. This possibility
is supported by (1) decreased BCR-mediated tyrosinethis possibility likely.
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phosphorylation of Vav1 in CD19/ B cells (Sato et al., presumably mediated by Syk, could be an additional
1997); (2) binding of Vav1/Vav2 to the tyrosine phosphor- mechanism. In this regard, Grb2 translocates Vav3 into
ylated CD19 after BCR stimulation (Doody et al., 2000; rafts, whereby Vav3 can be brought into a susceptible
Fujimoto et al., 2000; O’Rourke et al., 1998); and (3) state by its tyrosine phosphorylation through Syk. Indeed,
enhanced Vav1 recruitment to lipid rafts upon coligation BCR-mediated tyrosine phosphorylation of Vav3 was at-
of the BCR and the CD19/CD21 (Cherukuri et al., 2001). tenuated in Grb2-deficient DT40 B cells (Figure 1D).
Hence, according to this model, the residual Vav3 trans- In the case of BLNK-deficient DT40 B cells, despite
location to rafts in Grb2-deficient cells could be ac- a rapid decline of Vav3 residency in the rafts after 10
counted for by its recruitment to CD19. min stimulation, its tyrosine phosphorylation status was
As JNK activation is thought to lie downstream of Rac not significantly affected (Figure 1D). This result sug-
activation, the previous observation that BCR-mediated gests that Vav3 might not simply be back to the previous
JNK response normally occurred in BLNK/ primary B compartment after BCR stimulation. For instance, Vav3
cells (Tan et al., 2001) seems to contradict our finding might move to the internalization compartment, whereby
(Figure 2A). Since the low level of Rac1 activation still it could be brought into a relatively resistant state to
occurred even in BLNK-deficient primary B cells (Figure tyrosine phosphatases. Another possibility is that Vav3
2A), one possibility that reconciles these two findings is still able to associate with Syk, even after its exit from
is that the low level of Rac activation might be sufficient the rafts, thereby keeping its tyrosine phosphorylation
for the JNK activation. status. Then, a question arises about how BLNK partici-
BLNK appears rather to participate in sustaining Vav3 pates in the Rac1 pathway by holding Vav3 in lipid rafts.
localization in lipid rafts during BCR engagement. No BLNK might play a role in coupling Vav proteins to down-
significant influence of Grb2 and BLNK on each others’ stream effectors including their substrates. In the case
translocation was observed (Figure 4), which suggests of SLP-76, it has been suggested to function as a molec-
that Grb2 and BLNK are translocated to rafts indepen- ular bridge to couple Vav to Nck-associated PAK1, as
dently of each other. Then, in the rafts, trimeric complex Nck associates with SLP-76 (Bubeck Wardenburg et al.,
including Grb2, Vav3, and BLNK could be formed. To 1998). Given that Rac is enriched in lipid rafts (Arudchan-
account for the mechanism by which BLNK sustains dran et al., 2000; Phee et al., 2001) and there exist multi-
Vav3 localization in rafts, we propose two alternative, ple Rac targets, BLNK might serve to keep Vav proteins
but not necessarily mutually exclusive, possibilities. in the rafts for a sufficient period, thereby allowing them
First, BLNK, by its direct interaction with Vav3, might to couple to various effectors.
sequester the Vav3 from the internalization apparatus. In The availability of B cell lines deficient in Grb2, BLNK,
this regard, the Src-like adaptor molecule (SLAP) might or Vav3 has enabled us to isolate the connection between
function to counteract this BLNK action. In the case of Grb2/BLNK and Vav3 in B cells. Given the functional
TCR signal, SLAP was known to associate with Vav1 and overlapping of the Vav family proteins in BCR-mediated
to function as a negative regulator presumably through Rac activation, the mechanisms we have described for
bringing their targets into endosomes (Sosinowski et al., Vav3 are likely to be extrapolated to other Vav isoforms.
2000). Second, BLNK might contribute indirectly to the Since our data suggest the importance of Vav retention
prolonged Vav3 residency in the rafts during BCR en- time in lipid rafts for its optimal activation, further work
gagement. For instance, since BLNK also regulates the should be aimed at defining the mechanism of how Vav
PLC-	2/PKC- pathway (Kurosaki, 2002), it would be leaves the rafts.
possible that PKC-, after being activated, is involved
in Vav3 retention in the rafts. Supporting this possibility, Experimental Procedures
PKC-was recently demonstrated to play a role in local-
Cells, Mice, Abs, and Reagentsization of IKK
/IKK in the membrane rafts (Su et al.,
Wild-type and various mutant DT40 cells were cultured in RPMI2002).
1640 supplemented with 10% FCS, 1% chicken serum, 50 MThe necessity of stable association of Vav3 with lipid
2-mercaptoethanol (2-ME), 4 mM L-glutamine, and antibiotics. Es-rafts for its activation was demonstrated by experiments
tablishment of Grb2-, BLNK-, and Vav3-deficient DT40 cells as well
using its raft-targeted construct (LAT/Vav3) (Figure 5). as BLNK/ and Vav1/Vav2/ mice were described previously
This notion is also supported by recent data obtained (Doody et al., 2001; Hashimoto et al., 1998; Hayashi et al., 2000;
with Nef, a virulence factor that is required for efficient Inabe et al., 2002; Ishiai et al., 1999).
Anti-BLNK Ab, anti-Vav2 Ab, and anti-Vav3 Ab were obtained byviral replication and progression to AIDS (Fackler et al.,
immunizing rabbits with bacterially expressed GST fusion protein1999). Nef is constitutively localized in lipid rafts by its
containing partial amino acid sequences coding chicken BLNK,amino-terminal myristylation, and its PxxP motif binds
chicken Vav2, and chicken Vav3, respectively. Anti-chicken IgMthe C-terminal SH3 domain in Vav1. Then, Nef recruits
mAb, M4 (, ) (Chen et al., 1982), which was used for stimulation
Vav1 to the rafts, which in turn is critical for exerting of BCR, anti-chicken Lyn Ab, and anti-phosphotyrosine mAb (4G10)
Vav1 functions, such as activation of PAK1. were described previously (Ishiai et al., 1999). Anti-Grb2 Ab and
Despite constitutive localization of the LAT/Vav3 in anti--actin Ab were purchased from Santa Cruz Biotechnology.
Anti-Rac mAb and methyl--cyclodextrin (MCD) were purchasedrafts, activation status of Rac1 before BCR stimulation
from Upstate Biotechnology and Sigma Chemical Co., respectively.was only slightly upregulated. In fact, receptor ligation
was still required to activate Rac1 (Figure 5C), sug-
Expression Constructs and Transfectiongesting that localization of Vav3 in the rafts is a prerequi-
The cDNAs encoding wild-type chicken Vav3 and its GEF mutant
site, but additional BCR-mediated events are required constructs in the pApuro expression vector were described pre-
for Vav3 activation. Given the importance of tyrosine viously (Inabe et al., 2002). The chimeras (LAT/Vav3, LAT/Vav3
phosphorylation on Vav proteins in their activation (Bus- (mGEF), and LAT(mCS)/Vav3; see Figure 5A) were constructed by
using PCR method and cloned into expression vector pApuro. Thesetelo, 2000; Turner and Billadeau, 2002), this modification,
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constructs were transfected into Grb2- or BLNK-deficient DT40 cells conjugated cholera toxin B subunit (CTx-FITC) (Sigma Chemical
Co.) for 30 min and incubated with 5 g/ml M4 on ice for 10 min.by electroporation (550 V, 25 F) and selected in the presence
of puromycin (0.5 g/ml). Expression of transfected cDNAs was Stimulated cells were then washed in ice-cold PBS and visualized
by confocal microsope as described below.confirmed by Western blot analysis.
Generation of BLNK/Grb2 Double-Deficient DT40 Cells Capping Analysis
The targeting vectors, pBLNK-bsr and pBLNK-puro, were con- Capping analysis was carried out as described by Krawczyk et al.
structed by replacing the genomic fragment containing exons that (2002) with several modifications. In brief, retrovirally transduced
correspond to chicken BLNK amino acid residues 57-213 with bsr murine B cells were incubated with 2 g/ml biotinylated anti-mouse
and puro cassettes (Ishiai et al., 1999). These targeting vectors IgM mAb (PharMingen) on ice for 20 min. Stimulated cells were then
were sequentially transfected into Grb2-deficient cells, resulting in washed with ice-cold PBS and directly fixed with 0.4% paraformal-
generation of BLNK/Grb2 double-deficient DT40 cells. Selection for dehyde (PFA) or treated with 1 g/ml anti-rat IgG at 37C for 10 min
drug-resistant clones was performed by using blastcidin (50 g/ml) followed by fixation. BCR clustering was visualized by staining with
and/or puromycin (0.5 g/ml). TRITC-conjugated avidin (Sigma Chemical Co.). Carr Zeiss LSM 510
laser scanning confocal microscope was used for image acquisition.
Biochemical Analysis Cells were considered to have clustered BCR if the staining pattern
For immunoprecipitation, cells were solubilized in NP-40 lysis buffer was polarized to one side of the cell (1/4 of circumference).
supplemented with protease and phosphatase inhibitors (Ishiai et
al., 1999), and precleared lysates were incubated with proper Abs Flow Cytometric Analysis
and protein A-agarose. For Western blot analysis, immunoprecipi- Cell surface expression of BCR was analyzed by FACSCalibur (Bec-
tates, affinity precipitates, or whole-cell lysates were resolved on ton Dickinson) using FITC-conjugated anti-chicken IgM Ab (Bethyl)
SDS-PAGE, transferred to PVDF membrane (Bio-Rad Laboratories), or FITC-conjugated anti-mouse IgM mAb (PharMingen) and R-PE
and detected by the indicated Abs using ECL system (Amersham conjugated anti-mouse IgD mAb (Southern Biotechnology Associ-
Pharmacia Biotech). Affinity precipitation assays using GST-CRIB ates, Inc.).
(Cdc42/Rac interactive binding domain [CRIB] of rat PAK1 [amino
acid 1–125] fused to GST) (Manser et al., 1998) were described
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